Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs.

@article{Newman2003RadionuclideIT,
  title={Radionuclide imaging technologies and their use in evaluating asthma drug deposition in the lungs.},
  author={Stephen P. Newman and Gary R. Pitcairn and Peter H. Hirst and Lisa Rankin},
  journal={Advanced drug delivery reviews},
  year={2003},
  volume={55 7},
  pages={851-67}
}
Whole lung and regional lung deposition of inhaled asthma drugs in the lungs can be quantified using either two-dimensional or three-dimensional radionuclide imaging methods. The two-dimensional method of gamma scintigraphy has been the most widely used, and is currently considered the industry standard, but the three-dimensional methods (SPECT, single photon emission computed tomography; and PET, positron emission tomography) give superior regional lung deposition data and will undoubtedly be… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Similar Papers

Loading similar papers…